In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains

Retrieved on: 2021-06-21 09:11:15

Tags for this article:

Click the tags to see associated articles and topics

In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. View article details on hiswai:

Excerpt

Using a panel of monoclonal antibodies (mAbs) corresponding to many in advanced clinical development by Vir Biotechnology, AbbVie, AstraZeneca, ...

Article found on: www.nature.com